Sr MD Global Head Equity & FX McCourt Timothy Francis sold 97 shares of CME Group Inc. [CME]

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. CME Group Inc. shares valued at $18,361 were sold by McCourt Timothy Francis on Sep 20. At $189.29 per share, McCourt Timothy Francis sold 97 shares. The insider’s holdings dropped to 5,334 shares worth approximately $0.97 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Also, McCourt Timothy Francis sold 360 shares, netting a total of over 68,677 in proceeds. Following the sale of shares at $190.77 each, the insider now holds 5,431 shares.

Before that, Vroman Ken had sold 750 shares from its account. In a trade valued at $151,058, the Chief Transformation Officer traded CME Group Inc. shares for $201.41 each. Upon closing the transaction, the insider’s holdings decreased to 750 shares, worth approximately $2.27 million.

As published in their initiating research note from Rosenblatt on August 17, 2022, CME Group Inc. [CME] has been a Sell and the price target has been revised to $171. This represents a -6.45% premium over Wednesday’s closing price. Analysts at Raymond James downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in mid August. As of June 10, 2022, Atlantic Equities has increased its “Neutral” rating to a “an Overweight” for CME. Earlier on May 25, 2022, Oppenheimer upgraded its rating. Their new recommendation was “an Outperform” for CME stock which previously was a “a Perform”.

Analyzing CME’s Price Performance

On Wednesday, CME Group Inc. [NASDAQ: CME] plunged -2.79% to $182.03. The stock’s lowest price that day was $181.97, but it reached a high of $187.72 in the same session. During the last five days, there has been a drop of approximately -4.85%. Over the course of the year, CME Group Inc. shares have dropped approximately -20.32%. Shares of the company reached a 52-week high of $256.94 on 02/09/22 and a 52-week low of $181.97 on 09/21/22. A 50-day SMA is recorded $199.01, while a 200-day SMA reached $217.12. Nevertheless, trading volume fell to 1.37 million shares from 0.98 million shares the previous day.

Support And Resistance Levels for CME Group Inc. (CME)

According to the 24-hour chart, there is a support level at 180.09, which, if violated, would cause prices to drop to 178.16. In the upper region, resistance lies at 185.84. The next price resistance is at 189.66. RSI (Relative Strength Index) is 27.72 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -7.88, which suggests the price will decrease in the coming days. Percent R is at 99.71%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is CME Group Inc. subject to short interest?

Stocks of CME Group Inc. saw a sharp steep in short interest on Jul 14, 2022 dropping by -0.27 million shares to 3.0 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 3.27 million shares. A decline of -9.0% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.09 of the overall float, the days-to-cover ratio (short ratio) decline to 2.09.

Which companies own the most shares of CME Group Inc. (CME)?

According to Capital Research & Management Co filings, the company currently owns 33,077,028 shares, which is about 9.20% of the total CME shares outstanding. The investor’s shares have appreciated by 13,802 from its previous 13-F filing of 33063226.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $6,034,510,991. BlackRock Fund Advisors acquire a 0.64% interest valued at $3.19 billion while SSgA Funds Management, Inc. sold a -1,115,802 stake. A total of 462,033 shares of CME Group Inc. were sold by Capital Research & Management Co during the quarter, and -2,352,866 were sold by Edgewood Management LLC. In its current portfolio, Geode Capital Management LLC holds 6,753,871 shares valued at $1.32 billion.

In terms of CME Group Inc. share price expectations, FactSet research, analysts set an average price target of $217.47 in the next 12 months, up nearly 14.82% from the previous closing price of $187.25. Analysts anticipate CME Group Inc. stock to reach $270.00 by 2022, with the lowest price target being $168.00. In spite of this, 19 analysts ranked CME Group Inc. stock as an Overweight at the end of 2022. On May 16, 2022, Argus assigned a price target of “a Hold” to the stock and downgraded coverage with a $230.

LEAVE A REPLY

Please enter your comment!
Please enter your name here